214 related articles for article (PubMed ID: 30701464)
1. Thrombin generation profile in non-thrombotic factor V Leiden carriers.
Billoir P; Duflot T; Fresel M; Chrétien MH; Barbay V; Le Cam Duchez V
J Thromb Thrombolysis; 2019 Apr; 47(3):473-477. PubMed ID: 30701464
[TBL] [Abstract][Full Text] [Related]
2. Endogenous thrombin potential for predicting risk of venous thromboembolism in carriers of factor V Leiden.
Lincz LF; Lonergan A; Scorgie FE; Rowlings P; Gibson R; Lawrie A; Seldon M
Pathophysiol Haemost Thromb; 2006; 35(6):435-9. PubMed ID: 17565236
[TBL] [Abstract][Full Text] [Related]
3. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen.
Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Büller HR; Vandenbroucke JP
Lancet; 1995 Dec; 346(8990):1593-6. PubMed ID: 7500751
[TBL] [Abstract][Full Text] [Related]
4. Selective screening for the Factor V Leiden mutation: is it advisable prior to the prescription of oral contraceptives?
Schambeck CM; Schwender S; Haubitz I; Geisen UE; Grossmann RE; Keller F
Thromb Haemost; 1997 Dec; 78(6):1480-3. PubMed ID: 9423798
[TBL] [Abstract][Full Text] [Related]
5. The association of factor V Leiden with various clinical patterns of venous thromboembolism-the factor V Leiden paradox.
Hirmerova J; Seidlerova J; Subrt I
QJM; 2014 Sep; 107(9):715-20. PubMed ID: 24633260
[TBL] [Abstract][Full Text] [Related]
6. Homozygous factor V Leiden and double heterozygosity for factor V Leiden and prothrombin mutation.
Saemundsson Y; Sveinsdottir SV; Svantesson H; Svensson PJ
J Thromb Thrombolysis; 2013 Oct; 36(3):324-31. PubMed ID: 23054468
[TBL] [Abstract][Full Text] [Related]
7. Increased Activated Protein C Response Rates Reduce the Thrombotic Risk of Factor V Leiden Carriers But Not of Prothrombin 20210G>A Carriers.
Rühl H; Berens C; Winterhagen FI; Reda S; Müller J; Oldenburg J; Pötzsch B
Circ Res; 2019 Aug; 125(5):523-534. PubMed ID: 31314700
[TBL] [Abstract][Full Text] [Related]
8. Ocular vascular thrombotic events: a diagnostic window to familial thrombophilia (compound factor V Leiden and prothrombin gene heterozygosity) and thrombosis.
Glueck CJ; Wang P
Clin Appl Thromb Hemost; 2009 Feb; 15(1):12-8. PubMed ID: 18796459
[TBL] [Abstract][Full Text] [Related]
9. Heterozygosity for the factor V Leiden (G1691A) mutation predisposes renal transplant recipients to thrombotic complications and graft loss.
Wüthrich RP; Cicvara-Muzar S; Booy C; Maly FE
Transplantation; 2001 Aug; 72(3):549-50. PubMed ID: 11502996
[TBL] [Abstract][Full Text] [Related]
10. Prospective evaluation of hemostatic system activation and thrombin potential in healthy pregnant women with and without factor V Leiden.
Eichinger S; Weltermann A; Philipp K; Hafner E; Kaider A; Kittl EM; Brenner B; Mannhalter C; Lechner K; Kyrle PA
Thromb Haemost; 1999 Oct; 82(4):1232-6. PubMed ID: 10544904
[TBL] [Abstract][Full Text] [Related]
11. The impact of dalteparin (Fragmin) on thrombin generation in pregnant women with venous thromboembolism: significance of the factor V Leiden mutation.
Schambeck CM; Eberl E; Geisen U; Grossmann R; Keller F
Thromb Haemost; 2001 May; 85(5):782-6. PubMed ID: 11372668
[TBL] [Abstract][Full Text] [Related]
12. The procoagulant effects of factor V Leiden may be balanced against decreased levels of factor V and do not reflect in vivo thrombin formation in newborns.
Hyytiäinen S; Wartiovaara-Kautto U; Ulander VM; Kaaja R; Heikinheimo M; Petäjä J
Thromb Haemost; 2006 Mar; 95(3):434-40. PubMed ID: 16525570
[TBL] [Abstract][Full Text] [Related]
13. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
[TBL] [Abstract][Full Text] [Related]
14. Effects of oral contraceptives on hemostasis and thrombosis.
Rosing J; Tans G
Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S375-82. PubMed ID: 10368524
[TBL] [Abstract][Full Text] [Related]
15. Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study.
Couturaud F; Duchemin J; Leroyer C; Delahousse B; Abgrall JF; Mottier D;
Thromb Haemost; 2008 Jan; 99(1):223-8. PubMed ID: 18217158
[TBL] [Abstract][Full Text] [Related]
16. Venous thrombotic risk in family members of unselected individuals with factor V Leiden.
Lensen RP; Bertina RM; de Ronde H; Vandenbroucke JP; Rosendaal FR
Thromb Haemost; 2000 Jun; 83(6):817-21. PubMed ID: 10896231
[TBL] [Abstract][Full Text] [Related]
17. Sudden hearing loss followed by deep vein thrombosis and pulmonary embolism in a patient with factor V Leiden mutation.
Lovato A; Tormene D; Staffieri C; Breda S; Staffieri A; Marioni G
Int J Audiol; 2014 Sep; 53(9):625-8. PubMed ID: 24735015
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and management of factor V Leiden.
Campello E; Spiezia L; Simioni P
Expert Rev Hematol; 2016 Dec; 9(12):1139-1149. PubMed ID: 27797270
[TBL] [Abstract][Full Text] [Related]
19. High rate of unprovoked recurrent venous thrombosis is associated with high thrombin-generating potential in a prospective cohort study.
Besser M; Baglin C; Luddington R; van Hylckama Vlieg A; Baglin T
J Thromb Haemost; 2008 Oct; 6(10):1720-5. PubMed ID: 18680535
[TBL] [Abstract][Full Text] [Related]
20. Influence of single nucleotide polymorphisms on thrombin generation in factor V Leiden heterozygotes.
Segers O; Simioni P; Tormene D; Castoldi E
Thromb Haemost; 2014 Mar; 111(3):438-46. PubMed ID: 24226152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
